Citadel Advisors’s Longevity Health Holdings, Inc. Warrant XAGEW Stock Holding History

Citadel Advisors’s Portfolio XAGEW Stock Details XAGEW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-44,008	Closed	-$1.02K	–	14542
2025 Q2	$1.02K	Sell	44,008 -1,761	-4%	-$57	﹤0.01%	12265
2025 Q1	$1.14K	Sell	45,769 -1,067	-2%	-$37	﹤0.01%	14162
2024 Q4	$3.22K	Sell	46,836 -28,538	-38%	-$1.67K	﹤0.01%	14016
2024 Q3	$4.52K	Sell	75,374 -785	-1%	-$65	﹤0.01%	13558
2024 Q2	$6.09K	Sell	76,159 -22,314	-23%	-$2.24K	﹤0.01%	13359
2024 Q1	$15K	Buy	+98,473	New	+$16.7K	﹤0.01%	13211
2023 Q2	–	Sell	-18,277	Closed	-$2.98K	–	15402
2023 Q1	$2.98K	Buy	+18,277	New	+$3.32K	﹤0.01%	14086

Other funds holding XAGEW

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Citadel Advisors's XAGEW Position: Q3 2025 in Review

Citadel Advisors sold out of Longevity Health Holdings, Inc. Warrant (XAGEW) in Q3 2025, closing a stake of 44,008 shares — an estimated $1.02K sold.

Citadel Advisors first reported a position in XAGEW in Q1 2023 and held it in 7 quarters. The position peaked at $15K in Q1 2024. 1 fund tracked by Wall St. Rank holds XAGEW as of Q3 2025.

Citadel Advisors reported no remaining Longevity Health Holdings, Inc. Warrant position as of Q3 2025 after selling out during the quarter.
Citadel Advisors sold 44,008 Longevity Health Holdings, Inc. Warrant shares in Q3 2025, an estimated $1.02K.
Citadel Advisors first reported a position in Longevity Health Holdings, Inc. Warrant in Q1 2023 and held it in 7 quarters.
Citadel Advisors's Longevity Health Holdings, Inc. Warrant position peaked at $15K in Q1 2024.
1 fund tracked by Wall St. Rank held Longevity Health Holdings, Inc. Warrant as of Q3 2025.

Based on Citadel Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.